(Q46421463)

22 December 2017

title

Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression (English)

1 reference

22 December 2017

1 reference

1 reference

1 reference

Pejman Pirmoradi

1

1 reference

22 December 2017

Susan Roshan

series ordinal

2

1 reference

22 December 2017

Sofia S Nadeem

series ordinal

3

1 reference

22 December 2017

publication date

1 September 2008

1 reference

22 December 2017

American Journal of Health-System Pharmacy

published in

1 reference

22 December 2017

volume

65

1 reference

22 December 2017

issue

17

1 reference

22 December 2017

page(s)

1624-1626

1 reference

22 December 2017

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

A method for estimating the probability of adverse drug reactions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070641

31 March 2020

Identifiers

DOI

10.2146/AJHP070641

1 reference

22 December 2017

release_joqdcpmr6ndh5byyr2rphgztcu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/joqdcpmr6ndh5byyr2rphgztcu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

22 December 2017